Retatrutide Phase 2 data comes from 48-week trials, while Tirzepatide and Semaglutide data comes from 68 to 72 week studies
Accordingly, the semaglutide story is a case study in the intersection of patent strategy, regulatory processes, and public policy
Finally, the report discusses implications: how the Pfizer Metsera contest both reflects and accelerates shifts in pharma strategy, healthcare policy, and patient access
Photograph your progress monthly
Anyway, so there were a few of us, and interestingly, I was here on Long Island on the East Coast, and I had colleagues on the West Coast and in the Midwest, and wed get together and theyd say, Wow
The authors said future research will explore how patient characteristics, specific medications, and timing of therapy influence treatment trajectories, with the goal of informing more personalized and sustainable approaches to obesity care